With digital transformations all around us in healthcare, business, and our day-to-day lives, virtual clinical trials are increasingly relevant to the Life Sciences industry. Taking advantage of digitalization can have benefits to the clinical trial process including reduced costs, broader participant recruitment, and increased participant engagement and retention. But there are potential challenges including supply chain management of drug material, cyber security and privacy, and trial integrity and oversight in a decentralized framework. This dynamic session will explore the direct-to-patient clinical trial model and key considerations as companies design and conduct virtual clinical trials in 2021 and beyond.
BIO registration is required. If interested in registering, click here.